STRATEGIC RESEARCH PLAN

Coronavirus Research Institute- (COVRI) has a long- term strategic research plan, which can be summarized as follows:

Priority # 1: To test repurpose drugs which have been approved by the FDA for other indications for the prophylaxis and treatment of Covid-19.

Priority # 2: to develop promising drugs that have demonstrated a preliminary proof of safety and efficacy in other indications to evaluate its application for Covid-19.

Priority # 3: to develop promising vaccines that have demonstrated a preliminary proof of safety and efficacy to protect and prevent the on-set of Covid-19.

Priority # 4: to manage the infection control, including best ways to protect health care workers.

For further information on potential research collaboration, please contact us online at Contact Form. Thank you.